Bivalent Hemagglutinin Cleavage-Site Peptide Vaccines Protect Chickens from Lethal Infections with Highly Pathogenic H5N1 and H5N6 Avian Influenza Viruses
Frontiers in Bioscience-Landmark2024Vol. 29(2), pp. 61–61
Citations Over Time
Abstract
Dual-peptide vaccines containing cleavage-site peptides of both clades can protect chickens from highly pathogenic avian influenza virus infections.
Related Papers
- → Antigenic Drift in H5N1 Avian Influenza Virus in Poultry Is Driven by Mutations in Major Antigenic Sites of the Hemagglutinin Molecule Analogous to Those for Human Influenza Virus(2011)130 cited
- → Reassortant Avian Influenza A(H5N1) Viruses with H9N2-PB1 Gene in Poultry, Bangladesh(2013)63 cited
- Avian Influenza (Bird Flu) in Humans: Recent Scenario(2008)
- → Molecular aspects of avian influenza (H5N1) viruses isolated from humans(2000)58 cited
- → Molecular aspects of avian influenza (H5N1) viruses isolated from humans(2000)1 cited